ARCHIVES

Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Edward Harlow Returns to NCI As Special Assistant to Varmus

January 14, 2011

California Weighs Listing Tamoxifen As Carcinogen

October 27, 1995

NCCS Networker Volume 7 Issue 4, Assembly Edition 1993

September 13, 1993

In Brief: NCI Providing Information On Levamisole To Patients; Macdonald Jins Temple, Salick

July 21, 1989

In Brief: FASEB Report On Diet and Cancer Mortality Available; Don Poppke AO of Nursing Center

March 6, 1987

Rising Costs at NCI Threaten To Overtake Slim Increases In Budget Appropriations

March 28, 2014